我国科研人员开发可用于癌症免疫治疗的“纳米标记机器人”

Core Viewpoint - The research team led by Han Shuo from the Chinese Academy of Sciences has developed a "nano-marking robot" that can accurately identify cancer cells using engineered nanoenzymes responsive to deep red light or ultrasound, potentially paving the way for smarter and more efficient next-generation immunotherapies [1] Group 1: Research and Development - The team applied proximity labeling technology from chemical biology research to disease treatment [1] - The engineered nanoenzymes have shown good efficacy in both experimental mouse tumor models and in vitro clinical tumor samples [1] Group 2: Implications for Cancer Treatment - The development of this technology may open new avenues for the creation of advanced immunotherapies that can more effectively target cancer cells [1]